| 产品名称 | Peptides EP07893_1 | EBV LMP2 356-364 (HLA-A*02:01) |
|---|---|
| 目录号 | EP07893_1 |
| 别名 | EBV LMP2 356-364 (HLA-A*02:01) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP07893_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP07893_1 | EBV LMP2 356-364 (HLA-A*02:01)
品名：EBV LMP2 356-364 (HLA-A*02:01)
货号：EP07893_1
规格：1 mg; 5 mg
品牌：Peptides.de
产品描述
Antigen Peptide EBV LMP2 HLA-A*0201 (FLYALALLL) for stimulation of human EBV LMP2(356-364)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. LYALALLL is a linear peptidic epitope studied as part of Latent membrane protein 2 from Human herpesvirus 4 (Epstein Barr virus).
| Protein | Latent membrane protein |
| Species | Epstein-Barr virus (EBV; Human herpesvirus 4) |
| Application | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication | Cancer |
